Neurocrine Biosciences Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Neurocrine Biosciences Inc. filed 40 open-market sales worth $77.9 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Boyer David W., Chief Corp. Affairs Officer, sold 826 shares at $157.45 on 14 September 2026, filed 15 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 14 September 2026 | Boyer David W. | Chief Corp. Affairs Officer | Sale | 826 | $157.45 | $130,051 | Form 4 |
| 14 September 2026 | Abernethy Matt | Chief Financial Officer | Sale | 2,311 | $157.20 | $363,285 | Form 4 |
| 9 September 2026 | Benevich Eric | Chief Commercial Officer | Sale | 2,154 | $154.61 | $333,030 | Form 4 |
| 28 July 2026 | Norwalk Leslie V | Director | Sale | 1,250 | $182.01 | $227,508 | Form 4 |
| 10 July 2026 | Delaet Ingrid | Chief Regulatory Officer | Sale | 4,367 | $181.02 | $790,514 | Form 4 |
| 9 July 2026 | Lippoldt Darin | Chief Legal Officer | Sale | 10,000 | $179.60 | $1.8 million | Form 4 |
| 9 July 2026 | Delaet Ingrid | Chief Regulatory Officer | Sale | 8,433 | $178.72 | $1.5 million | Form 4 |
| 8 July 2026 | Delaet Ingrid | Chief Regulatory Officer | Sale | 2,737 | $178.54 | $488,672 | Form 4 |
| 7 July 2026 | Delaet Ingrid | Chief Regulatory Officer | Sale | 3,401 | $178.57 | $607,305 | Form 4 |
| 29 June 2026 | Lippoldt Darin | Chief Legal Officer | Sale | 8,110 | $170.03 | $1.4 million | Form 4 |
| 29 June 2026 | Lippoldt Darin | Chief Legal Officer | Sale | 1,690 | $170.81 | $288,676 | Form 4 |
| 26 June 2026 | Lippoldt Darin | Chief Legal Officer | Sale | 200 | $169.56 | $33,913 | Form 4 |
| 5 June 2026 | Sherwin Stephen A | Director | Sale | 7,883 | $163.81 | $1.3 million | Form 4 |
| 5 June 2026 | Sherwin Stephen A | Director | Sale | 2,549 | $164.44 | $419,156 | Form 4 |
| 5 June 2026 | Sherwin Stephen A | Director | Sale | 6,896 | $165.79 | $1.1 million | Form 4 |
| 5 June 2026 | Sherwin Stephen A | Director | Sale | 5,829 | $166.56 | $970,859 | Form 4 |
| 5 June 2026 | Sherwin Stephen A | Director | Sale | 1,843 | $167.31 | $308,357 | Form 4 |
| 4 June 2026 | Norwalk Leslie V | Director | Sale | 1,250 | $168.06 | $210,072 | Form 4 |
| 2 June 2026 | Cooke Julie | Chief Human Resources Officer | Sale | 14,214 | $154.83 | $2.2 million | Form 4 |
| 2 June 2026 | Cooke Julie | Chief Human Resources Officer | Sale | 5,466 | $155.46 | $849,726 | Form 4 |
| 2 June 2026 | Cooke Julie | Chief Human Resources Officer | Sale | 4,216 | $156.77 | $660,925 | Form 4 |
| 2 June 2026 | Cooke Julie | Chief Human Resources Officer | Sale | 9,521 | $157.62 | $1.5 million | Form 4 |
| 2 June 2026 | Cooke Julie | Chief Human Resources Officer | Sale | 3,520 | $158.59 | $558,236 | Form 4 |
| 1 June 2026 | Onyia Jude | Chief Scientific Officer | Sale | 11,000 | $160.25 | $1.8 million | Form 4 |
| 29 May 2026 | Delaet Ingrid | Chief Regulatory Officer | Sale | 2,261 | $156.71 | $354,321 | Form 4 |
| 27 May 2026 | Onyia Jude | Chief Scientific Officer | Sale | 11,000 | $155.53 | $1.7 million | Form 4 |
| 26 May 2026 | Boyer David W. | Chief Corp. Affairs Officer | Sale | 3,888 | $156.64 | $609,023 | Form 4 |
| 19 May 2026 | Gorman Kevin Charles | Director | Sale | 245,088 | $154.33 | $37.8 million | Form 4 |
| 15 May 2026 | Pops Richard F | Director | Sale | 15,000 | $157.65 | $2.4 million | Form 4 |
| 12 May 2026 | Norwalk Leslie V | Director | Sale | 3,810 | $155.01 | $590,601 | Form 4 |
| 16 January 2026 | Gano Kyle | Chief Executive Officer | Sale | 34,588 | $132.70 | $4.6 million | Form 4 |
| 16 January 2026 | Gano Kyle | Chief Executive Officer | Sale | 1,812 | $132.71 | $240,478 | Form 4 |
| 16 December 2025 | Norwalk Leslie V | Director | Sale | 1,190 | $155.09 | $184,558 | Form 4 |
| 15 December 2025 | Norwalk Leslie V | Director | Sale | 5,000 | $152.23 | $761,144 | Form 4 |
| 8 December 2025 | Lippoldt Darin | Chief Legal Officer | Sale | 4,376 | $159.65 | $698,615 | Form 4 |
| 3 December 2025 | Lyons Gary A | Director | Sale | 15,000 | $152.61 | $2.3 million | Form 4 |
| 28 November 2025 | Benevich Eric | Chief Commercial Officer | Sale | 5,970 | $151.74 | $905,881 | Form 4 |
| 25 November 2025 | Morrow George J | Director | Sale | 15,000 | $143.37 | $2.2 million | Form 4 |
| 5 November 2025 | Rastetter William H | Director | Sale | 18,000 | $151.82 | $2.7 million | Form 4 |
| 4 November 2025 | Gano Kyle | Chief Executive Officer | Sale | 300 | $141.97 | $42,591 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Neurocrine Biosciences Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.